1. Home
  2. CRVS vs WEYS Comparison

CRVS vs WEYS Comparison

Compare CRVS & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$8.57

Market Cap

459.0M

Sector

Health Care

ML Signal

HOLD

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$30.61

Market Cap

280.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
WEYS
Founded
2014
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Apparel
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
459.0M
280.9M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CRVS
WEYS
Price
$8.57
$30.61
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$13.75
N/A
AVG Volume (30 Days)
945.3K
19.8K
Earning Date
11-04-2025
11-04-2025
Dividend Yield
N/A
3.51%
EPS Growth
N/A
N/A
EPS
N/A
2.54
Revenue
N/A
$279,843,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$12.14
Revenue Growth
N/A
N/A
52 Week Low
$2.54
$25.51
52 Week High
$9.60
$38.24

Technical Indicators

Market Signals
Indicator
CRVS
WEYS
Relative Strength Index (RSI) 54.47 52.32
Support Level $8.03 $30.20
Resistance Level $9.17 $31.88
Average True Range (ATR) 0.55 1.01
MACD -0.06 0.09
Stochastic Oscillator 38.22 73.73

Price Performance

Historical Comparison
CRVS
WEYS

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.

Share on Social Networks: